Evinacumab promising treatment for pediatric patients with homozygous familial hypercholesterolemia Dr. Shravani Dali7 Nov 2023 11:45 AM ISTEvinacumab promising treatment for pediatric patients with homozygous familial hypercholesterolemia suggests a new study published in the...
Evinacumab effective and well tolerated for LDL cholesterol lowering in refractory hypercholesterolemia patients: JAMA Medha Baranwal19 Sept 2023 11:30 AM ISTUSA: A recent study published in JAMA Cardiology has demonstrated the potential utility of evinacumab as an effective and generally well-tolerated...
Evinacumab gets FDA nod for treatment of rare homozygous FH in children Medha Baranwal12 Feb 2021 7:30 PM ISTUSA: The U.S. Food and Drug Administration (FDA) has given its approval to Regeneron's evinacumab (Evkeeza) as an adjunct to other low-density...
Pushing limits in dyslipidemia management: Novel drug Evinacumab gives promising results dr. Abhimanyu Uppal21 Dec 2020 5:37 PM ISTA new drug target is emerging for the treatment of patients in whom the LDL cholesterol level remains too high despite treatment with existing...
Evinacumab cuts LDL cholesterol by half in high risk patients: NEJM study Dr. Kamal Kant Kohli16 Nov 2020 11:00 AM ISTResearchers at Icahn School of Medicine of Mount Sinai have found in phase 2 study that the investigational drug evinacumab reduced low-density...
PCSK9 inhibitor Evinacumab may significantly lower LDL cholesterol in FH: NEJM Medha Baranwal21 Aug 2020 11:30 AM ISTDelhi: Evinacumab significantly lowers LDL cholesterol levels in patients with homozygous familial hypercholesterolemia receiving maximum...
Evinacumab cuts LDL cholesterol by half in familial hypercholesterolemia Dr. Kamal Kant Kohli3 April 2020 5:45 PM ISTMonoclonal antibody, Evinacumab effective for the full spectrum of homozygous familial hypercholesterolemia
